Nu Skin Enterprises, Inc. (NUS) recently posted first-quarter earnings of 28 cents per share, excluding an item. The result exceeded analysts’ estimates by 17%. Management said the company continues to produce growth in a difficult economic climate.

Company Description
Nu Skin Enterprises is a $1 billion direct selling company that markets and distributes premium quality personal care, nutrition and technology products through a global network of more than 750,000 active independent distributors and preferred customers. The company operates three core brands, Nu Skin, Pharmanex, and Big Planet.

The Nu Skin brand has a line of more than 100 premium skin treatment and other personal care products. With a team of more than 100 in-house scientists, Pharmanex uses a pharmaceutical approach that is setting the standard for the dietary supplement industry. Big Planet brings the benefits of technology to everyone with innovative products like Maxvault, a line of products that provide the easiest way to preserve, organize, share, and enjoy your photos and home movies.

Nu Skin Enterprises operates in 48 international markets across the Americas, the Asia Pacific region and Europe, with more than 75 percent of revenue coming from Asia.

A Solid Quarter

The company recently posted first-quarter earnings of 28 cents per share, excluding an item. The result exceeded analysts’ estimates by 17%.

Management said the company continues to produce growth in a difficult economic climate.

“Our personal care business generated solid revenue growth of 19 percent in the quarter, driven by the continued success of the Nu Skin Galvanic Spa System. In addition, our restructuring efforts over the past three years are increasing profitability, as demonstrated by a significant improvement in first-quarter operating margin when excluding restructuring charges,” said Truman Hunt, president and chief executive officer.

Upbeat Estimates

The company sees second-quarter earnings ranging between 29 to 31 cents per share. For the year, Nu Skin’s earnings guidance ranges between $1.12 and $1.20 per share.

Brokerage analysts upped their second-quarter projections to 30 cents per share from last month’s 29 cents. Analysts’ full-year forecasts of $1.16 per share are above the previous month’s $1.13.

Outstanding Fundamentals

Nu Skin’s return on equity (ROE) of 22% dwarfs the industry average of 5%. The company’s net profit margin of 5.1% tops the industry average of 1.4%. NUS also rewards shareholders with an industry-leading dividend yield of 3.4%.

Zacks Investment Research
View original at: Zacks.com News Feed

1. (NUS) Nu Skin Enterprises, Inc. – Value – Zacks Rank BuyNu Skin Enterprises, Inc. (NUS) is playing the youth revolution as sales of its anti-aging...
2. (GA) Giant Interactive Group, Inc. – Growth And Income – Zacks Rank BuyGiant Interactive Group Inc. (GA) is seeing upbeat earnings forecasts ahead of reporting tomorrow. The...
3. Corning Inc. – Growth And Income – Zacks Rank BuyCorning Inc. (GLW) recently declared a quarterly dividend of 5 cents per share, noting that...
4. (GA) Giant Interactive Group Inc. – Growth And Income – Zacks Rank BuyGiant Interactive Group Inc. (GA) recently posted stellar results for the fourth quarter. Earnings per...
5. (STE) Steris Corp. – Growth And Income – Zacks Rank BuySteris Corp. (STE) continues to see higher forecasts from analysts. Current fiscal year earnings estimates...
6. (BBY) Best Buy Co. Inc. – Growth And Income – Zacks Rank BuyBest Buy Co. Inc. (BBY) is watching analysts boost earnings estimates as its share price...

Search Posts by Tag: Nu Skin Enterprises Inc. | NUS | Drugs Wholesale | Services

RSS Feeds by Tag: Nu Skin Enterprises Inc. | NUS | Drugs Wholesale | Services |

Other Posts by: vitalstocks | RSS Feed for this author